Our data revealed that up-regulation of CYP2J2 inhibited HRVEC viability, reduced the expression of PCNA, and inhibited migration; however, Terfenadone induced opposite effects on HRVEC viability and migration in hypoxia-induced retinopathy. The gene discussed is PCNA; the disease is retinal disorder.